Australia markets open in 4 hours 38 minutes

Miromatrix Medical Inc. (MIRO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.92-0.22 (-3.04%)
At close: 1:00PM EST

Miromatrix Medical Inc.

10399 West 70th Street
Eden Prairie, MN 55344
United States
952 942 6000

Sector(s):Β Healthcare
Industry:Β Biotechnology
Full-time employees:Β 36

Key executives

NameTitlePayExercisedYear born
Dr. Jeffrey James Ross Ph.D.CEO & Director323.49kN/A1976
Mr. Brian D. NieburChief Financial Officer178.81kN/A1964
Dr. John Joseph BarryVP of R&DN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company also develops organ-derived biological products for various applications, such as soft tissue reinforcement and wound care. It uses its perfusion decellularization/recellularization technology to engineer transplantable organs for the people who need them. Miromatrix Medical Inc. has strategical partnerships with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. Miromatrix Medical Inc. was formerly known as TayTech, Inc. The company was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Corporate governance

Miromatrix Medical Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.